Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p

Liu J., Wu M., Feng G., Li R., Wang Y., Jiao J.

Laboratory Study on Hip, published in Int J Mol Med (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Mol Med (2020)
Reported sample size
—
Source database
Europe PMC
PMID
32705245
PMCID
PMC7387089
DOI
10.3892/ijmm.2020.4672
Citations
19

Abstract (original English)

Human bone marrow‑derived mesenchymal stem cells (HBMSCs) have the potential of multidirectional differentiation and self‑renewal, which is important for the formation of human bone. It has been reported that long non‑coding RNAs (lncRNAs) serve important roles in HBMSC osteogenic differentiation. The current study aimed to investigate the roles of long intergenic non‑protein coding RNA 00707 (LINC00707) and microRNA (miR)‑103a‑3p in the osteogenic differentiation of HBMSCs. Reverse transcription‑quantitative PCR (RT‑qPCR) was performed to detect the expression levels of LINC00707, miR‑103a‑3p and osteogenesis‑related genes (Alkaline phosphatase, osteocalcin, osteopontin and RUNX family transcription factor 2) in HBMSCs cultured in proliferation medium (PM) and osteogenic medium (OM). Mineralized matrix deposition was measured using Alizarin Red S staining. The protein expression levels of osteogenesis‑related genes were detected by western blotting. The relationships between LINC00707, miR‑103a‑3p and dickkopf WNT signaling pathway inhibitor 1 (DKK1) were predicted using Starbase and TargetScan7.2, and were further assessed with a dual‑luciferase reporter assay. After 21 days of cell culture, the results indicated that expression of LINC00707 was downregulated, and those of miR‑103a‑3p and osteogenesis‑related genes were upregulated in OM‑cultured HBMSCs. However, there was no

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cell LineMesenchymal Stem CellsHumansIntercellular Signaling Peptides and ProteinsMicroRNAsCell DifferentiationDown-RegulationUp-RegulationOsteogenesisRNA, Long Noncoding

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research